These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 32787558)

  • 1. Rituximab desensitization in pediatric acute lymphoblastic leukemia with severe anaphylaxis.
    V Villarreal-González R; E de Lira-Quezada C; N González-Díaz S; L Carrasco-Díaz L; González-Llano O
    J Oncol Pharm Pract; 2021 Apr; 27(3):747-750. PubMed ID: 32787558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab desensitization in three patients with severe rituximab allergy.
    Öztürk E; Özyiğit LP; Öztürk AB; Akay MO; Çetiner M; Ferhanoğlu B
    Curr Probl Cancer; 2017; 41(5):349-354. PubMed ID: 28860080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful oxaliplatin desensitization protocol in a patient with colorectal metastatic cancer.
    de Lira-Quezada CE; Villarreal-Gonzalez RV; Gonzalez-Diaz SN; Carrasco-Diaz LL
    J Oncol Pharm Pract; 2021 Mar; 27(2):490-493. PubMed ID: 32635810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Desensibilización a Rituximab en paciente con proteinuria persistente secundaria a LES].
    Servín-Suárez N; Méndez-Gómez A; Korkowski-Uviña K; Carrillo-Murillo H; Torres-Rojo E; Ortega-Cisneros M; Ochoa-García IV
    Rev Alerg Mex; 2023 Sep; 70(4):. PubMed ID: 37933938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient.
    Sahiner UM; Yavuz ST; Gökce M; Buyuktiryaki B; Altan I; Aytac S; Tuncer M; Tuncer A; Sackesen C
    Pediatr Int; 2013 Aug; 55(4):531-3. PubMed ID: 23910807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.
    Wong JT; Long A
    J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid desensitization to brentuximab vedotin after severe anaphylaxis in the treatment of refractory Hodgkin's lymphoma.
    V Villarreal-Gonzalez R; N Gonzalez-Diaz S; E de Lira-Quezada C; Gómez-Almaguer D; Gómez-De León A; Acuña-Ortega N
    J Oncol Pharm Pract; 2021 Mar; 27(2):505-508. PubMed ID: 32686619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protracted anaphylaxis and cytokine release syndrome 6 days after rituximab desensitization.
    Finkel KA; Jung H; Kim H; Coleman DT
    Ann Allergy Asthma Immunol; 2024 Jul; 133(1):112-114. PubMed ID: 38615738
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete metabolic response after carboplatin desensitization in Peritoneal Carcinomatosis.
    Villarreal-González RV; González-Díaz SN; Vidal-Gutiérrez O; Zayas-Villanueva OA; Solís-Lara H; Santos-Fernández WJ; Casas-Murillo CA; López-Méndez A
    J Oncol Pharm Pract; 2022 Sep; 28(6):1441-1445. PubMed ID: 35119322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to Rituximab in Children.
    Liccioli G; Simonini G; Melani F; Giovannini M; Ricci S; Sarti L; Cavallin M; Barni S; Marrani E; Mori F
    Pharmacology; 2021; 106(5-6):341-344. PubMed ID: 33202411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma.
    August KJ; Farooki S; Fulbright JM; August A; Portnoy JM; Pommert L; Burke MJ; Guest EM
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28021. PubMed ID: 31571395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated
    Verma A; Chen K; Bender C; Gorney N; Leonard W; Barnette P
    Pediatr Hematol Oncol; 2019 Aug; 36(5):277-286. PubMed ID: 31296092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Drug Desensitization With Rituximab in 24 Cases: A Single-Center Experience.
    Görgülü B; Seval GC; Kendirlinan R; Toprak SK; Özcan M; Bavbek S
    J Investig Allergol Clin Immunol; 2019; 29(6):468-470. PubMed ID: 31530515
    [No Abstract]   [Full Text] [Related]  

  • 16. Desensitization to rituximab in a multidisciplinary setting.
    Amorós-Reboredo P; Sánchez-López J; Bastida-Fernández C; do Pazo-Oubiña F; Borràs-Maixenchs N; Giné E; Valero A; Creus-Baró N
    Int J Clin Pharm; 2015 Oct; 37(5):744-8. PubMed ID: 25999014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of palifermin following severe anaphylaxis to pegaspargase in a pediatric patient with acute lymphoblastic leukemia.
    Kaminski KS; Beach CL; Peden DB; Le U; Roehrs PA
    J Oncol Pharm Pract; 2016 Apr; 22(2):354-6. PubMed ID: 25567519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln With Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients.
    Wu J; Chen C; Huang S; Shen S; Chen J; Zhang S
    Technol Cancer Res Treat; 2020; 19():1533033820980113. PubMed ID: 33287663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of anti-L-asparaginase antibody and L-asparaginase activity levels in a pediatric patient with acute lymphoblastic leukemia and hypersensitivity to native Escherichia coli L-asparaginase during desensitization courses.
    Kawahara Y; Morimoto A; Hayase T; Kashii Y; Fukuda T; Momoi MY
    J Pediatr Hematol Oncol; 2014 Mar; 36(2):e91-3. PubMed ID: 23689289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.